Paracetamol Market Updates

Skyquest Technology's expert advisors continuously track and analyze the latest developments and updates related to paracetamol market. Our team of analysts stay abreast of all the recent news stories shaping the industry including new product launches by major companies, strategic partnerships, M&As, Patent filings and industry and regulatory developments.

Paracetamol Market News

in Paracetamol
  • USA FDA announced new February 2025 regulations for the safe over-the-counter consumption of medicines like paracetamol to prevent overdose risks. The new rule features more explanatory packaging, restrictions on the highest dosage per pill, and enhanced child protection levels in liquid solutions.
  • In January 2024, the European Medicines Agency (EMA) launched a thorough safety profile review of paracetamol following fears of cases of liver damage. The review will initiate new warnings and dose instructions in Europe, affecting retail and prescription market strategies of pharma players.
  • India's Ministry of Health and Family Welfare added fresh price controls to lifesaving drugs like paracetamol as part of the National List of Essential Medicines during November 2023. The step aims at containing healthcare price inflation but complicates making paracetamol for producers with steep price ceilings and curbs on margins.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Paracetamol Market size was valued at USD 761.7 Million in 2023 and is poised to grow from USD 796.79 Million in 2024 to USD 1124.47 Million by 2032, growing at a CAGR of 4.4% in the forecast period (2025-2032).

The global paracetamol market is very competitive with the likes of McKesson, Johnson & Johnson, and GlaxoSmithKline dominating the market. The competitors are trying to strengthen product portfolios through acquisitions and strategic partnerships. Regulators such as the FDA and EMA continue to inspect for compliance and safety, shaping market conditions. Further investment in sustainable packaging and safer formulations also reflects their reaction to global regulatory and consumer pressures. 'Johnson & Johnson ', 'GSK Consumer Healthcare', 'Sanofi', 'Mallinckrodt Pharmaceuticals', 'Granules India Limited', 'Teva Pharmaceutical Industries Ltd. ', 'Sun Pharmaceutical Industries Ltd. ', 'Dr. Reddy's Laboratories', 'Cipla Inc. ', 'Novartis', 'Pfizer ', 'Abbott Laboratories ', 'Bayer AG ', 'Zydus Lifesciences ', 'Mylan (Viatris)', 'Aurobindo Pharma', 'Lupin Limited', 'Torrent Pharmaceuticals', 'Glenmark Pharmaceuticals', 'Alkem Laboratories'

The rising rate of pain diseases, including arthritis, migraines, and back pain, is primarily fuelling the global market for paracetamol. Chronic pain, as estimated by the National Institutes of Health (NIH), affects 20% of the adult population across the globe, prompting governments and organizations like McKesson Corporation and GlaxoSmithKline to promote wider access to proper pain control strategies.

Shift Towards Sustainable Packaging Solutions: Governments worldwide, particularly in the EU and North America, are increasingly enforcing sustainability regulations for pharmaceutical products. This trend is pushing paracetamol manufacturers to adopt eco-friendly packaging solutions. The WHO has highlighted the importance of reducing pharmaceutical waste, prompting companies to innovate in recyclable materials for paracetamol packaging.

What makes North America the top market for paracetamol in 2024?

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Paracetamol Market
Paracetamol Market

Report ID: SQMIG35I2374

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE